While cannabis is the most commonly used illicit substance, studies surrounding its association with urologic cancers are few and limited by small samples, uncontrolled confounders, or infrequent patient cannabis use. We aimed to investigate the association between cannabis use and risk of genitourinary malignancies, using a large claims database. We retrospectively assessed United States adults between 2004 and 2024 in the TriNetX database.
